A Systematic Review on Steroid Withdrawal Between 3 and 6 Months After Kidney Transplantation

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Transplantation

• Publication date

  2010-08-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/TP.0b013e3181e58912PMID 20574419
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• KDIGO clinical practice guideline for the care of kidney transplant recipients.

  2009cited by this paper
• Prospective, Randomized Trial on Late Steroid Withdrawal in Pediatric Renal Transplant Recipients Under Cyclosporine Microemulsion and Mycophenolate Mofetil

  2009cited by this paper
• Trends in Organ Donation and Transplantation in the United States, 1997–2006

  2008influential reference
• Trends in Organ Donation and Transplantation in the United States, 1996–2005

  2007cited by this paper
• Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine

  2006cited by this paper
• Three-Year Observational Follow-up of a Multicenter, Randomized Trial on Tacrolimus-Based Therapy with Withdrawal of Steroids or Mycophenolate Mofetil after Renal Transplant

  2006cited by this paper
• Minimization of Immunosuppressive Therapy After Renal Transplantation: Results of a Randomized Controlled Trial

  2005influential reference
• Prednisone‐Free Maintenance Immunosuppression—A 5‐Year Experience

  2005cited by this paper
• Long‐Term Prospective Study of Steroid Withdrawal in Kidney and Heart Transplant Recipients

  2005cited by this paper
• Steroid Withdrawal in Renal Transplant Patients on Triple Therapy with a Calcineurin Inhibitor and Mycophenolate Mofetil: A Meta-analysis of Randomized, Controlled Trials

  2004influential reference
• Steroid‐Withdrawal at 3 Days After Renal Transplantation with Anti‐IL‐2 Receptor α Therapy: A Prospective, Randomized, Multicenter Study

  2004cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Interaction revisited: the difference between two estimates

  2003cited by this paper
• Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study.

  2002cited by this paper
• Low-dose and rapid steroid withdrawal in renal transplant patients treated with tacrolimus and mycophenolate mofetil.

  2002influential reference
• Successful withdrawal of steroid after renal transplantation.

  2001cited by this paper
• Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection.

  2000cited by this paper
• A meta-analysis of immunosuppression withdrawal trials in renal transplantation.

  2000influential reference
• Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group.

  1999cited by this paper
• Steroid-free immunosuppression in cyclosporine-treated renal transplant recipients: a meta-analysis.

  1993cited by this paper
• Low-dose steroid therapy in cyclosporine-treated renal transplant recipients with well-functioning grafts. The Canadian Multicentre Transplant Study Group.

  1992cited by this paper

• Effectiveness of steroid-free immunosuppressive regimens after kidney transplantation: the pioneering experience of a brazilian center

  2025cites this paper
• Shield or risk immunosuppressant choice and Pneumocystis pneumonia after kidney transplant.

  2025cites this paper
• Impact of corticosteroid withdrawal on bone mineral density after kidney transplantation

  2025cites this paper
• Efetividade de regimes imunossupressores livres de corticoides após o transplante renal: a experiência pioneira de um centro brasileiro

  2025cites this paper
• Early Steroid Withdrawal in Kidney Transplant Recipients: CON

  2025cites this paper
• Exploring the Impact of Diabetes on Kidney Transplant: Patient Outcomes and Management Strategies

  2025cites this paper
• Diabetic Kidney Disease in Post-Kidney Transplant Patients

  2024cites this paper
• An update review of post‐transplant diabetes mellitus: Concept, risk factors, clinical implications and management

  2024cites this paper
• Management of Early Post-Transplant Hyperglycemia by Dedicated Endocrine Care Improves Glycemic Outcomes

  2024cites this paper
• Urinary Tract Infections in Kidney Transplant Patients: An Open Challenge—Update on Epidemiology, Risk Factors and Management

  2024cites this paper
• Problem to solution; from mammalian skin grafts to renal allograft rejection: a tale of 66 years of evolution of our understanding.

  2023cites this paper
• Post-Transplantations-Diabetes mellitus

  2023cites this paper
• Long-term Prolonged-release Tacrolimus-based Immunosuppression in De Novo Kidney Transplant Recipients: 5-Y Prospective Follow-up of Patients in the ADVANCE Study

  2023cites this paper
• Prevention of Post-Transplant Diabetes Mellitus: Towards a Personalized Approach

  2022cites this paper
• Interventions Against Posttransplantation Diabetes: A Scientific Rationale for Treatment Hierarchy Based on Literature Review.

  2022cites this paper
• New Approaches to Cardiovascular Disease and Its Management in Kidney Transplant Recipients

  2021cites this paper
• Challenges Surrounding Induction Protocols in Children

  2021cites this paper
• A Current Review of the Etiology, Clinical Features, and Diagnosis of Urinary Tract Infection in Renal Transplant Patients

  2021cites this paper
• Impact of kidney transplantation on functional status

  2021cites this paper
• Clinical Relevance of Corticosteroid Withdrawal on Graft Histological Lesions in Low-Immunological-Risk Kidney Transplant Patients

  2021cites this paper
• Early Corticosteroid Cessation vs Long-term Corticosteroid Therapy in Kidney Transplant Recipients: Long-term Outcomes of a Randomized Clinical Trial.

  2021cites this paper
• Diabetes in Kidney Transplantation.

  2021cites this paper
• Effect of Early Steroid Withdrawal on Posttransplant Diabetes Among Kidney Transplant Recipients Differs by Recipient Age

  2021cites this paper
• Posttransplant Diabetes Mellitus and Immunosuppression Selection in Older and Obese Kidney Recipients

  2021influential citation
• Management of post‐transplant diabetes: immunosuppression, early prevention, and novel antidiabetics

  2020cites this paper
• 5‐Year outcomes of the prospective and randomized CISTCERT study comparing steroid withdrawal to replacement of cyclosporine with everolimus in de novo kidney transplant patients

  2020cites this paper
• Immunosuppression Regimen Use and Outcomes in Older and Younger Adult Kidney Transplant Recipients: A National Registry Analysis

  2020cites this paper
• Panel-reactive Antibody and the Association of Early Steroid Withdrawal With Kidney Transplant Outcomes

  2020cites this paper
• Alteraciones del metabolismo de la glucosa en donante y receptor

  2020cites this paper
• Posttransplantationsdiabetes mellitus

  2020cites this paper
• Treatment of dyslipidemia in kidney transplantation

  2020cites this paper
• Transplantácia obličky a metabolický syndróm

  2019cites this paper
• Updates on urinary tract infections in kidney transplantation

  2019cites this paper
• Chronic Immunosuppression Medications

  2019cites this paper
• Incidence, Risk Factors, and Follow-Up of Diabetes Mellitus After Liver Transplant: A Prospective Study From Iran.

  2019cites this paper
• Peripheral blood lymphocyte subsets change after steroid withdrawal in renal allograft recipients: a prospective study

  2019cites this paper
• Glucocorticoids use in kidney transplant setting

  2018cites this paper
• Ten‐year observational follow‐up of a randomized trial comparing cyclosporine and tacrolimus therapy combined with steroid withdrawal in living‐donor renal transplantation

  2018cites this paper
• Late Steroid Withdrawal Following AB0-Incompatible Renal Transplantation.

  2018cites this paper
• Prospective randomized study of conversion from tacrolimus to cyclosporine A to improve glucose metabolism in patients with posttransplant diabetes mellitus after renal transplantation

  2018cites this paper
• Successful steroid withdrawal guided by surveillance biopsies—A single‐center experience

  2018cites this paper
• Higher tacrolimus blood concentration is related to increased risk of post-transplantation diabetes mellitus after living donor liver transplantation.

  2018cites this paper
• Steroid withdrawal protocols in Renal Transplantation

  2018cites this paper
• Pretransplant HbA1c and Glucose Metabolism Parameters in Predicting Posttransplant Diabetes Mellitus and Their Course in the First 6 Months After Living-Donor Renal Transplant.

  2017cites this paper
• Defining a Steroid Withdrawal Protocol in a newly established Kidney Transplantation Unit

  2017cites this paper
• Two Decades of Tacrolimus in Renal Transplant: Basic Science and Clinical Evidences.

  2017cites this paper
• De fi ning a Steroid Withdrawal Protocol in a newly established Kidney Transplantation Unit

  2017cites this paper
• Steroid withdrawal after renal transplantation: a retrospective cohort study

  2017cites this paper
• Steroid free immunosuppression is associated with enhanced Th1 transcripts in kidney transplantation.

  2017cites this paper
• Comparative Effectiveness of Tacrolimus-Based Steroid Sparing versus Steroid Maintenance Regimens in Kidney Transplantation: Results from Discrete Event Simulation

  2017cites this paper
• Dynamics of Glucose Metabolism After Kidney Transplantation

  2017cites this paper
• Prevalence and risk factors of new onset diabetes after liver transplantation (NODAT): A single Egyptian center experience

  2017cites this paper
• Metabolic syndrome and new onset diabetes after kidney transplantation.

  2017cites this paper
• Risk Factors of Recurrence of Diabetic Nephropathy in Renal Transplants.

  2016cites this paper
• Lymphocyte-depleting induction and steroid minimization after kidney transplantation: A review.

  2016cites this paper
• Immunosuppression in the elderly renal allograft recipient: a systematic review.

  2016cites this paper
• Evolution of Immunosuppressive Agents in Renal Transplantation: An Updated Review

  2016cites this paper
• Early Steroid Withdrawal in Recipients of a Kidney Transplant From a Living Donor: Experience of a Single Mexican Center.

  2016cites this paper
• Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial.

  2016cites this paper
• Corticosteroid minimization in renal transplantation: Careful patient selection enables feasibility

  2016cites this paper
• National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence‐Based Regimen Selection

  2016cites this paper
• Efficacy and safety of tacrolimus compared with ciclosporin‐A in renal transplantation: 7‐year observational results

  2016cites this paper
• POST-TRANSPLANT DIABETES MELLITUS (PTDM)

  2016cites this paper
• Immunosuppressive Drugs in Solid Organ Transplantation

  2016cites this paper
• Immunosuppression: Induction, Maintenance, and Steroid Avoidance Protocols

  2016cites this paper
• Twelve-Month and Five-Year Analyses of Risk Factors for New-Onset Diabetes After Transplantation in a Group of Patients Homogeneous for Immunosuppression.

  2015cites this paper
• Chronic maintenance immunosuppression in renal transplantation: the unrealized goal of improved long-term outcomes.

  2015cites this paper
• Diabetes Mellitus and Prediabetes on Kidney Transplant Waiting List- Prevalence, Metabolic Phenotyping and Risk Stratification Approach

  2015cites this paper
• Treating posttransplantation diabetes mellitus

  2015cites this paper
• Glucocorticoids in nephrology II: indications and dosage.

  2015cites this paper
• Immunosuppression and Post-transplant Hyperglycemia.

  2015cites this paper
• New‐onset diabetes after liver transplantation and its impact on complications and patient survival

  2015cites this paper
• Diabetes mellitus de novo postrasplante

  2015cites this paper
• Risk of Major Hemorrhage after Kidney Transplantation

  2015cites this paper
• Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions

  2014cites this paper
• Comparative Effectiveness of Tacrolimus-Based Steroid Sparing versus Steroid Withdrawal Regimens in Patients with Kidney Transplantation: Results from Discrete Event Simulation Modeling

  2014cites this paper
• Alemtuzumab and minimization immunotherapy in kidney transplantation: long-term results of comparison with rabbit anti-thymocyte globulin and standard triple maintenance therapy.

  2014cites this paper
• Obesity, metabolic syndrome and diabetes mellitus after renal transplantation: prevention and treatment.

  2014cites this paper
• Optimal use of corticosteroids in nephrology

  2014cites this paper
• Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

  2013cites this paper
• Is it safe to withdraw steroids within seven days of renal transplantation?

  2013cites this paper
• Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial

  2013cites this paper
• Immunsuppressive Therapie nach Nierentransplantation Vermeidung von Steroiden und Calcineurininhibitoren

  2013cites this paper
• Effect of Corticosteroid Withdrawal on Tacrolimus and Mycophenolate Mofetil Exposure in a Randomized Multicenter Study

  2013influential citation
• Immunsuppressive Therapie nach Nierentransplantation

  2013cites this paper
• Early steroid withdrawal compared with steroid avoidance correlates with graft failure among kidney transplant recipients with an history of diabetes.

  2013cites this paper
• Future trends in organ transplant recipients--important issues for dermatologists.

  2012cites this paper
• UNGRADED SUGGESTIONS FOR CLINICAL CARE IMPLEMENTATION AND AUDIT

  2012cites this paper
• Cyclosporine: Molecular Action to Clinical Therapeutics

  2012cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Prednisolone and Prednisone in Solid Organ Transplantation

  2012cites this paper
• Steroid-free chronic immunosuppression in renal transplantation

  2012cites this paper
• The KHA-CARI Guidelines Caring for Australasians with Renal Impairment The Kidney Health Australia-Caring for Australasians with Renal Impairment (KHA-CARI) Guidelines Adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

  2012cites this paper
• Does Everolimus Increase Donor‐Specific HLA Antibodies in Kidney Transplant Recipients?

  2012cites this paper
• Hyperuricemia in adult renal allograft recipients: prevalence and predictors.

  2012cites this paper
• Prospective Controlled Protocol for Three Months Steroid Withdrawal with Tacrolimus, Basiliximab, and Mycophenolate Mofetil in Renal Transplant Recipients

  2012cites this paper
• Urinary tract infection in renal transplantation

  2012cites this paper
• Tacrolimus-Based, Steroid-Free Regimens in Renal Transplantation: 3-Year Follow-Up of the ATLAS Trial

  2012cites this paper
• Application of pharmacometrics for covariate selection and dose optimization of tacrolimus in adult kidney transplant recipients

  2012cites this paper
• New-onset diabetes and nephropathy after renal transplantation.

  2011cites this paper
• Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.

  2011cites this paper